Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolina Alarcón-Payer

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Anti-Cancer Drugs|July 15, 2024
Dermatological toxicity associated with the use of gilteritinib in relapsed acute myeloid leukemia with FLT3 mutation: a case reportAlicia Martín Roldán, Carolina Alarcón-Payer, María Del Mar Sánchez Suárez, et al.
Anti-Cancer Drugs|February 4, 2025
Association between nilotinib-induced hyperbilirubinemia and UGT1A1 polymorphisms in a chronic myeloid leukemia patientCarolina Alarcón-Payer, María Del Mar Sánchez Suárez, Alicia Martín Roldán, et al.
Anti-Cancer Drugs|November 26, 2024
Sorafenib as maintenance therapy in FLT3+ acute myeloid leukemia post allogeneic transplantation: a case reportAlicia Martín Roldán, Carolina Alarcón-Payer, María Del Mar Sánchez Suárez, et al.
Journal of Personalized Medicine|October 27, 2022
Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid LeukemiaCarolina Alarcón-Payer, María Del Mar Sánchez Suárez, Alicia Martín Roldán, et al.
Crystal Growth & Design|May 12, 2025
Impact of the Coformer Carbon-Chain Length on the Properties of Haloperidol Pharmaceutical SaltsFrancisco J Acebedo-Martínez, Carolina Alarcón-Payer, Alicia Domínguez-Martín, et al.
Pharmaceutics|May 27, 2023
A Real-World Evidence-Based Study of Long-Term Tyrosine Kinase Inhibitors Dose Reduction or Discontinuation in Patients with Chronic Myeloid LeukaemiaAlicia Martín Roldán, María Del Mar Sánchez Suárez, Carolina Alarcón-Payer, et al.
Molecular Pharmaceutics|April 25, 2025
Enhanced Drug Loading Capacity Using the Dual Metformine-Dexketoprofren Salt on Nanoapatite MaterialsFrancisco J Acebedo-Martínez, Alicia Domínguez-Martín, Carolina Alarcón-Payer, et al.
The Annals of Pharmacotherapy|July 11, 2015
Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host DiseasePaloma García-Martín, Carolina Alarcón-Payer, Elisa López-Fernández, et al.
Inorganic Chemistry|January 18, 2006
A windmill-shaped hexacopper(II) molecule built up by template core-controlled expansion of diaquatetrakis(mu2-adeninato-N3,N9)dicopper(II) with aqua(oxydiacetato)copper(II)Josefa María González-Pérez, Carolina Alarcón-Payer, Alfonso Castiñeiras, et al.
Crystal Growth & Design|March 9, 2026
Multicomponent Oxicam-Metformin Salts: Toward a Strategy for Enhancing Solubility and StabilityEstephany Muñoz-Hernández, Carolina Alarcón-Payer, Antonio Frontera, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Anti-Cancer Drugs|July 15, 2024
Dermatological toxicity associated with the use of gilteritinib in relapsed acute myeloid leukemia with FLT3 mutation: a case reportAlicia Martín Roldán, Carolina Alarcón-Payer, María Del Mar Sánchez Suárez, et al.
Anti-Cancer Drugs|February 4, 2025
Association between nilotinib-induced hyperbilirubinemia and UGT1A1 polymorphisms in a chronic myeloid leukemia patientCarolina Alarcón-Payer, María Del Mar Sánchez Suárez, Alicia Martín Roldán, et al.
Anti-Cancer Drugs|November 26, 2024
Sorafenib as maintenance therapy in FLT3+ acute myeloid leukemia post allogeneic transplantation: a case reportAlicia Martín Roldán, Carolina Alarcón-Payer, María Del Mar Sánchez Suárez, et al.
Journal of Personalized Medicine|October 27, 2022
Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid LeukemiaCarolina Alarcón-Payer, María Del Mar Sánchez Suárez, Alicia Martín Roldán, et al.
Crystal Growth & Design|May 12, 2025
Impact of the Coformer Carbon-Chain Length on the Properties of Haloperidol Pharmaceutical SaltsFrancisco J Acebedo-Martínez, Carolina Alarcón-Payer, Alicia Domínguez-Martín, et al.
Pharmaceutics|May 27, 2023
A Real-World Evidence-Based Study of Long-Term Tyrosine Kinase Inhibitors Dose Reduction or Discontinuation in Patients with Chronic Myeloid LeukaemiaAlicia Martín Roldán, María Del Mar Sánchez Suárez, Carolina Alarcón-Payer, et al.
Molecular Pharmaceutics|April 25, 2025
Enhanced Drug Loading Capacity Using the Dual Metformine-Dexketoprofren Salt on Nanoapatite MaterialsFrancisco J Acebedo-Martínez, Alicia Domínguez-Martín, Carolina Alarcón-Payer, et al.
The Annals of Pharmacotherapy|July 11, 2015
Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host DiseasePaloma García-Martín, Carolina Alarcón-Payer, Elisa López-Fernández, et al.
Inorganic Chemistry|January 18, 2006
A windmill-shaped hexacopper(II) molecule built up by template core-controlled expansion of diaquatetrakis(mu2-adeninato-N3,N9)dicopper(II) with aqua(oxydiacetato)copper(II)Josefa María González-Pérez, Carolina Alarcón-Payer, Alfonso Castiñeiras, et al.
Crystal Growth & Design|March 9, 2026
Multicomponent Oxicam-Metformin Salts: Toward a Strategy for Enhancing Solubility and StabilityEstephany Muñoz-Hernández, Carolina Alarcón-Payer, Antonio Frontera, et al.
Pageof 3